206 results on '"Matsuo, K."'
Search Results
2. Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic
- Author
-
Oba J, Toriya M, Uwamino Y, and Matsuo K
- Subjects
covid-19 ,pcr test ,clinical laboratory ,systems engineering ,diagram ,temporary system ,Public aspects of medicine ,RA1-1270 - Abstract
Junna Oba,1 Masako Toriya,2 Yoshifumi Uwamino,3 Koichi Matsuo4 1Department of Extended Intelligence for Medicine, the Ishii-Ishibashi Laboratory, Keio University School of Medicine, Tokyo, Japan; 2Global Research Institute, Keio University, Tokyo, Japan; 3Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan; 4Collaborative Research Resources, Keio University School of Medicine, Tokyo, JapanCorrespondence: Masako Toriya, Global Research Institute, Keio University, 2-15-45 Mita, Minato-ku, Tokyo, 108-8345, Japan, Tel +81-3-5427-1379, Fax +81-3-5427-1703, Email masako.toriya@keio.jpBackground: During the COVID-19 pandemic, there was an increasing need to expand diagnostic testing in hospitals. At Keio University Hospital (KUH), clinical staff were concerned that the demand for PCR testing might exceed the capacity of the Clinical Laboratory. In response, basic researchers at Keio University School of Medicine (KUSM) set out to build a new, collaborative, PCR testing system. To be authorized to perform such diagnostic PCR testing, KUSM registered its core laboratory as an external clinical laboratory (ECL).Methods: In the pandemic, there was a pressure to build the PCR system quickly. Speed required discussions that developed a shared understanding of the unprecedented, new KUH/KUSM PCR system. To design, construct, and archive the new PCR testing system, we used a systems engineering (SE) approach. This included diagram visualization of functional flows and application of the Unified Architecture Framework (UAF), both of which are often used in system building. We considered daily demand for PCR testing at KUH and KUSM, and daily COVID-19 infections in Japan.Results: We operated the collaborative PCR testing system from August 2020 to June 2022. Given public health insurance reimbursement policies, KUH focused on individuals with suspicious symptoms, while the ECL at KUSM screened samples from asymptomatic individuals. KUSM performed about half as many tests as KUH. Interviewing KUH staff revealed that diagrams helped promote a better understanding of the KUH/KUSM PCR testing system.Conclusion: When designing temporary systems that may be repurposed in the future, we suggest using an SE approach with diagrams and UAF perspectives. This approach will enable stakeholders to understand what is being proposed to be built, and facilitate achieving an informed consensus on the proposed system. We suggest that SE approaches should be widely used in projects that involve building and operating complex, collaborative systems, and documenting the process. Keywords: COVID-19, PCR test, clinical laboratory, systems engineering, diagram, temporary system
- Published
- 2024
3. Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts
- Author
-
Downward, G.S., Hystad, P., Tasmin, S., Abe, S.K., Saito, E, Rahman, M.S., Islam, M.R., Gupta, P.C., Sawada, N., Malekzadeh, R., You, S.L., Ahsan, H., Park, S.K., Pednekar, M.S., Tsugane, S., Etemadi, A., Chen, C.J., Shin, A., Chen, Y., Boffetta, P., Chia, K.S., Matsuo, K., Qiao, Y.L., Rothman, N., Zheng, W., Inoue, M., Kang, D., Lan, Q., and Vermeulen, R.C.H
- Published
- 2024
- Full Text
- View/download PDF
4. EP09.91: Stratification of fetal therapy indication for the fetus with severe tricuspid valve dysplasia.
- Author
-
Ishii, Y., Nagano, H., Hayashida, Y., Fujisaki, T., Mori, M., Matsuo, K., Asada, D., Kanaya, T., Tsumura, S., and Aoki, H.
- Subjects
FETAL ultrasonic imaging ,MATERNAL age ,EBSTEIN'S anomaly ,TRICUSPID valve ,CONGENITAL heart disease - Abstract
This article discusses the severity and clinical course of tricuspid valve dysplasia (TVD) in fetuses and explores suitable cases for fetal treatment. The study presents the SAS score and TRIPP score for 20 TVD cases from 2013 to 2023. The results show that a SAS score and TRIPP score of 6 or higher indicate a higher risk of intrauterine fetal death (IUFD) and may be suitable for fetal treatment. The article concludes that stratifying severity using these scores is valuable in determining the need for fetal treatment. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
5. EP09.33: Utility of novel echocardiographic measurements to improve prenatal diagnosis of coarctation of the aorta.
- Author
-
Fujisaki, T., Ishii, Y., Takahashi, K., Mori, M., Matsuo, K., Asada, D., Kanaya, T., Tsumura, S., Kayatani, F., and Aoki, H.
- Subjects
RECEIVER operating characteristic curves ,SUBCLAVIAN artery ,THORACIC aorta ,DUCTUS arteriosus ,CAROTID artery ,AORTIC coarctation - Abstract
This article, published in the journal Ultrasound in Obstetrics & Gynecology, discusses the challenges of prenatal diagnosis of coarctation of the aorta (CoA) and aims to identify a novel formula based on fetal echocardiographic measures to improve prenatal identification of CoA. The study compared echocardiographic evaluations of 30 patients with suspected CoA and found that measurements of aortic isthmus diameter, ductus arteriosus diameter/aortic isthmus diameter, and distal aortic arch (DA) index showed significant differences between the groups. The DA index was found to be the most effective measurement, with a cutoff value of 1.28 indicating cases requiring surgical intervention. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. EP09.18: Utility of the angle between the right aortic arch and first branch for detecting double aortic arch via fetal echocardiography.
- Author
-
Mori, M., Ishii, Y., Takahashi, K., Nagano, H., Hayashida, Y., Fujisaki, T., Matsuo, K., Asada, D., Hisaaki, A., and Kayatani, F.
- Subjects
THORACIC aorta ,MIRROR images ,RECEIVER operating characteristic curves ,SENSITIVITY & specificity (Statistics) ,TRACHEA - Abstract
This article, published in the journal "Ultrasound in Obstetrics & Gynecology," discusses the utility of using fetal echocardiography to differentiate between a double aortic arch (DAA) and a right aortic arch with mirror image branching (mRAA). DAA is a condition that can cause airway and esophageal compression after birth, while mRAA rarely causes tracheal compressive symptoms. The study found that the angle between the right aortic arch and first branch (RF angle) was significantly sharper in the DAA group compared to the mRAA group. The researchers determined that an RF angle of less than 71° had 100% sensitivity and 75% specificity for the detection of DAA. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
7. EP09.06: A case of incomplete double aortic arch with steep RF angle between aortic arch and first branch.
- Author
-
Inoue, Y., Ishii, Y., Nagano, H., Hayashida, Y., Fujisaki, T., Mori, M., Matsuo, K., Asada, D., Takahashi, K., Tsumura, S., and Aoki, H.
- Subjects
THORACIC aorta ,SUBCLAVIAN artery ,FETAL echocardiography ,CAROTID artery ,BRACHIOCEPHALIC trunk - Abstract
This article discusses a case of incomplete double aortic arch (iDAA), a congenital vascular anomaly that can cause respiratory problems. The diagnosis of iDAA is challenging, especially during the fetal period. The article highlights the importance of a steep angle between the right aortic arch (RAA) and the first branch (RF angle) as a potential indicator of iDAA. The case study describes a fetus with a steep RF angle on prenatal fetal echocardiography, leading to the diagnosis of iDAA after birth. The article concludes that a steep RF angle in a case of RAA suggests the possibility of iDAA. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
8. The incidence of meniscal cyst formation following meniscal repair using the all-inside suture anchor device is comparable to conventional techniques.
- Author
-
Goto K, Sanada T, Honda E, Sameshima S, Inagawa M, Ishida Y, Matsuo K, Kuzuhara R, and Iwaso H
- Abstract
Purpose: Post-operative meniscal cyst formation occurs following all-inside device meniscal repair. This study aimed to compare the incidence of cysts in patients who underwent meniscal repair with and without all-inside suture devices., Methods: This retrospective study included 227 knees that underwent meniscal repair between 2021 and 2022. The incidence of post-operative meniscal cysts was compared between patients who underwent repair using an all-inside suture anchor device (Group SA) and those who did not use an anchor (Group NA), based on post-operative magnetic resonance imaging (MRI) findings. Risk factors, such as the number of anchors used, were investigated. Using a subgroup analysis, the incidence of meniscal cysts based on the type of device used was investigated., Results: Groups SA and NA comprised 125 and 102 knees, respectively. Group SA had 11 cases of cysts (9% incidence), whereas Group NA had 7 cases (7% incidence), and no statistically significant difference was observed ( p = 0.63). Symptomatic cysts were observed in two patients (1.6%) in Group SA, whereas none was observed in Group NA (0%); the difference was not significant ( p = 0.50). Factors such as the number of anchors and sutures used and MRI timing were not identified as risk factors. Cyst incidence varied according to anchor type: Stryker AIR+ (4 out of 55, 7%), Smith & Nephew Fast-Fix 360 (7 out of 56, 13%) and Arthrex Fiber Stitch (0 out of 26, 0%), with no significant difference found ( p = 0.14)., Conclusion: The incidence of cysts in patients undergoing meniscal repair with an all-inside suture anchor device was 9%, showing no significant difference compared with Group NA. Cyst incidence was not affected by device type., Level of Evidence: Level III, retrospective comparative study., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). Journal of Experimental Orthopaedics published by John Wiley & Sons Ltd on behalf of European Society of Sports Traumatology, Knee Surgery and Arthroscopy.)
- Published
- 2024
- Full Text
- View/download PDF
9. Secondary databases in gynecologic cancer research.
- Author
-
Hicks-Courant K, Ko EM, Matsuo K, Melamed A, Nasioudis D, Rauh-Hain JA, Uppal S, Wright JD, and Ramirez PT
- Subjects
- Humans, Female, United States, SEER Program, Biomedical Research standards, Genital Neoplasms, Female therapy, Databases, Factual
- Abstract
Observational and cohort studies using large databases have made important contributions to gynecologic oncology. Knowledge of the advantages and potential limitations of commonly used databases benefits both readers and reviewers. In this review, researchers familiar with National Cancer Database (NCDB), Surveillance, Epidemiology, and End Results Program (SEER), SEER-Medicare, MarketScan, Healthcare Cost and Utilization Project (HCUP), National Surgical Quality Improvement Program (NSQIP), and Premier, describe each database, its included data, access, management, storage, highlights, and limitations. A better understanding of these commonly used datasets can help readers, reviewers, and researchers to more effectively interpret and apply study results, evaluate new research studies, and develop compelling and practice-changing research., Competing Interests: Competing interests: None declared., (© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
10. Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation.
- Author
-
Woll SM, Lee MW, Neuman MK, Pino C, Klar M, Roman LD, Wright JD, and Matsuo K
- Subjects
- Humans, Female, Middle Aged, Retrospective Studies, SEER Program, Neoplasm Grading, Adult, Aged, Chemotherapy, Adjuvant, Survival Rate, Carcinoma, Endometrioid pathology, Carcinoma, Endometrioid drug therapy, Carcinoma, Endometrioid surgery, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Ovarian Neoplasms surgery, Ovarian Neoplasms mortality, Neoplasm Staging
- Abstract
Objective: Given limited real-world practice data evaluating the National Comprehensive Cancer Network clinical practice guidelines for possible post-operative chemotherapy omission as a treatment option for patients with stage IC grade 1 endometrioid ovarian carcinoma, this population-based study examined the association between post-operative chemotherapy and overall survival in this tumor group., Methods: The National Cancer Institute's Surveillance, Epidemiology, and End Results program was retrospectively queried. The study population was 1207 patients with stage IC grade 1-3 endometrioid ovarian carcinoma who received primary cancer-directed surgery from 2007 to 2020. Overall survival was assessed with multivariable Cox proportional hazard regression model., Results: The median age was 52, 54, and 55 years for grade 1, 2, and 3 groups, respectively (p=0.02). Grade 1 and 2 tumors were more common than grade 3 tumors (n=508 (42.1%), n=493 (40.8%), and n=206 (17.1%), respectively). Chemotherapy use rate for grade 1 tumors was lower compared with grade 2-3 tumors (67.9%, 76.5%, and 78.6%, respectively, p<0.001). When nodal evaluation was performed for grade 1 tumors, among patients who did not receive post-operative chemotherapy and among those who did, 5-year overall survival rate exceeded 90% (93.3% and 96.0%, respectively), with statistically non-significant hazard estimates (adjusted hazard ratio (aHR) 1.54, 95% CI 0.63 to 3.73). In contrast, post-operative chemotherapy omission for patients who did not undergo nodal evaluation was associated with decreased overall survival (5-year rates 82.3% vs 96.0%, aHR 5.41, 95% CI 1.95 to 15.06). Results were similar for node-evaluated grade 2 tumors (5-year overall survival rates, 94.6% and 94.4% for node-evaluated post-operative chemotherapy omission and administration, respectively), but not in grade 3 tumors., Conclusion: The results of this population-based study may partially support the current clinical practice guidelines for post-operative chemotherapy omission as a possible option for patients with stage IC grade 1 endometrioid adenocarcinoma of the ovary for those who had lymph node evaluation. Observed data were also supportive for node-evaluated grade 2 tumors, warranting further evaluation., Competing Interests: Competing interests: Consultant, AstraZeneca, CooperSurgical, Immunogen, and KLS Martin (MK); research grant, Merck, royalties, UpToDate, honorarium, American College of Obstetrics and Gynecology (JDW); consultant, Cardiff Oncology, Nutcracker, participation in the Steering Committee for the Global Coalition of Adaptive Research (LDR); none for others., (© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
11. Salivary Antimicrobial Peptide in Patients With Dementia Before and After Clinical Oral Rehabilitation Programme: A Randomised Controlled Trial.
- Author
-
Chen MA, Yang YH, Liu CK, Matsuo K, Hsu CC, Lin YC, and Huang HL
- Abstract
Background: Emerging evidence suggests a link between salivary metabolite changes and neurodegenerative dementia, with antimicrobial peptides (AMPs) implicated in its pathogenesis., Objective: We investigated the effects of a clinical oral rehabilitation programme tailored for dementia patients on salivary flow rate, AMP levels and oral health-related quality of life (OHRQoL)., Methods: Eligible patients were randomly assigned to either the experimental group (EG; n = 28) or the control group (CG; n = 27). Both groups received a leaflet on oral health. In addition, the EG received an oral care intervention that included individual lessons on oral muscle exercises and oral self-care practices. Saliva samples and OHRQoL data were collected at baseline and follow-up visits. Generalised estimating equation models were used to analyse the changes over time., Results: At the 3-month follow-up, EG showed significantly lower histatin 5 (HTN-5) levels (β = -0.08; effect size [ES] = 0.72) than CG. At 6 months, EG exhibited improved salivary flow rate (β = 0.89; ES = 0.89) and OHRQoL (β = 6.99; ES = 1.31) compared to CG. Changes in salivary flow rate (β = 4.03), HTN-5 level (β = -0.78) and beta-defensin 2 level (BD-2) (β = -0.91) at 3 months predicted improved OHRQoL at 6 months (all p < 0.05)., Conclusions: Our clinical oral rehabilitation programme reduced the level of salivary HTN-5, increased salivary flow rate and enhanced OHRQoL in dementia patients. Furthermore, changes in salivary flow rate, HTN-5 level and BD-2 level were associated with improvements in patients' OHRQoL., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
12. Confounding in Epidemiological Studies on Assessment of the Impact of Genetic Factors on Disease Risk: The Problem of Redundant Adjustment.
- Author
-
Kasugai Y, Oze I, Koyanagi YN, Taniyama Y, Ito H, Imoto I, and Matsuo K
- Subjects
- Humans, Genetic Predisposition to Disease, Risk Factors, Epidemiologic Studies, Confounding Factors, Epidemiologic
- Published
- 2024
- Full Text
- View/download PDF
13. Age at menarche by birth cohort: A pooled analysis of half a million women in Asia.
- Author
-
Abe SK, Nishio M, Huang HL, Leung CY, Islam MR, Rahman MS, Saito E, Shin A, Merritt MA, Choi JY, Katagiri R, Mohammadi Z, Shu XO, Wakai K, Sawada N, Ideno Y, Tamakoshi A, Seow WJ, Koh WP, Sakata R, Hozawa A, Kim J, Nagata C, Sugawara Y, Park SK, Kweon SS, Azizi F, Malekzadeh R, Moy FM, Pourfarzi F, Gao YT, Kubo Y, Hirabayashi M, Nagai K, Kimura T, Yuan JM, Kanemura S, Wada K, Kang D, Shin MH, Khalili D, Poustchi H, Rezaianzadeh A, Mansour-Ghanaei F, Najafi F, Mohebbi I, Boffetta P, Lee JE, Matsuo K, Rothman N, Qiao YL, Zheng W, and Inoue M
- Abstract
Objectives: To evaluate changes in the age at menarche in Asian populations., Study Design: Retrospective cohort study., Methods: We included 548,830 women from six countries in Asia. The data were sourced from 20 cohorts participating in the Asia Cohort Consortium (ACC) and two additional cohort studies: Japan Multi-institutional Collaborative Cohorts (J-MICC), and Japan Nurse Health Study (JNHS) with data on age at menarche. Joinpoint regression was used to evaluate changes in age at menarche by birth year and by country., Results: The study includes data from cohorts in six Asian countries namely, China, Iran, Japan, Korea, Malaysia and Singapore. Birth cohorts ranged from 1873 to 1995. The mean age of menarche was 14.0 years with a standard deviation (SD) of 1.4 years, ranged from 12.6 to 15.5 years. Over 100 years age at menarche showed an overall decrease in all six countries. China showed a mixed pattern of decrease, increase, and subsequent decrease from 1926 to 1960. Iran and Malaysia experienced a sharp decline between about 1985 and 1990, with APC values of -4.48 and -1.24, respectively, while Japan, South Korea, and Singapore exhibited a nearly linear decline since the 1980s, notably with an APC of -3.41 in Singapore from 1993 to 1995., Conclusions: Overall, we observed a declining age at menarche, while the pace of the change differed by country. Additional long-term observation is needed to examine the contributing factors of differences in trend across Asian countries. The study could serve as a tool to strengthen global health campaigns., (Copyright © 2024 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Association between family history with lung cancer incidence and mortality risk in the Asia Cohort Consortium.
- Author
-
Kishida R, Yin X, Abe SK, Rahman MS, Saito E, Islam MR, Lan Q, Blechter B, Rothman N, Sawada N, Tamakoshi A, Shu XO, Hozawa A, Kanemura S, Kim J, Sugawara Y, Park SK, Kweon SS, Ahsan H, Boffetta P, Chia KS, Matsuo K, Qiao YL, Zheng W, Inoue M, Kang D, and Seow WJ
- Abstract
Family history of lung cancer (FHLC) has been widely studied but most prospective cohort studies have primarily been conducted in non-Asian countries. We assessed the association between FHLC with risk of lung cancer (LC) incidence and mortality in a population of East Asian individuals. A total of 478,354 participants from 11 population-based cohorts in the Asia Cohort Consortium were included. A Cox proportional hazards regression model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). A total of 7,785 LC incident cases were identified. FHLC (any LC subtype) was associated with an increased risk of LC incidence (HR = 1.45, 95% CI = 1.30-1.63). The positive association was observed in men and women (HR = 1.44, 95% CI = 1.26-1.66 in men; HR = 1.47, 95% CI = 1.22-1.79 in women), and in both never-smokers and ever-smokers (HR = 1.43, 95% CI = 1.18-1.73 in never-smokers; HR = 1.46, 95% CI =1.27-1.67 in ever-smokers). FHLC was associated with an increased risk of lung adenocarcinoma (HR = 1.63, 95% CI: 1.36-1. 94), squamous cell carcinoma (HR = 1.88, 95% CI: 1.46-2.44), and other non-small cell LC (HR = 1.94, 95% CI: 1.02-3.68). However, we found no evidence of significant effect modification by sex, smoking status, and ethnic groups. In conclusion, FHLC was associated with increased risk of LC incidence and mortality, and the associations remained consistent regardless of sex, smoking status and ethnic groups among the East Asian population., (© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.)
- Published
- 2024
- Full Text
- View/download PDF
15. Salt-Induced Hydrophobic C-Terminal Region of α-Synuclein Triggers Its Fibrillation under the Mimic Physiologic Condition.
- Author
-
Imaura R, Kawata Y, and Matsuo K
- Subjects
- Humans, alpha-Synuclein chemistry, alpha-Synuclein metabolism, Hydrophobic and Hydrophilic Interactions, Sodium Chloride chemistry, Sodium Chloride pharmacology, Amyloid chemistry
- Abstract
α-Synuclein (αS) causes Parkinson's disease due to the structural alteration into amyloid fibrils that form after the interaction with synaptic membranes in neurons. To understand the alternation mechanism, the effect of salt (NaCl) on the interaction of αS with synaptic mimic membrane was characterized at the molecular level because salt triggered the amyloid fibril formation. The membrane-bound conformation (or the initial conformation before fibrillation) showed that NaCl decreased the number of helical structures and Tyr residues interacting with the membrane surface compared to when NaCl was absent, implying an increase in solvent-exposed regions. The N-terminal region of αS interacted with the membrane, forming the helical structures regardless of NaCl, while the C-terminal region formed a random structure with weak membrane interaction, but NaCl inhibited the interaction of its hydrophobic area, suggesting that salt promoted amyloid fibril formations by exposing the hydrophobic C-terminal region, which can intermolecularly interact with free αS.
- Published
- 2024
- Full Text
- View/download PDF
16. Esophagectomy for esophageal cancer in patients with a history of total pharyngolaryngectomy: a Japanese nationwide retrospective cohort study.
- Author
-
Okamura A, Watanabe M, Okui J, Kuriyama K, Shiraishi O, Kurogochi T, Abe T, Sato H, Miyata H, Kawaguchi Y, Sato Y, Nagano H, Takeno S, Nakajima M, Matsuo K, Murakami K, Takebayashi K, Matsumoto S, Okumura T, Kakeji Y, Kono K, Oridate N, Toh Y, Takeuchi H, and Katori Y
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Japan epidemiology, Postoperative Complications epidemiology, Postoperative Complications etiology, Neoplasms, Second Primary epidemiology, Reoperation statistics & numerical data, Treatment Outcome, Pneumonia epidemiology, Pneumonia etiology, East Asian People, Esophagectomy adverse effects, Esophagectomy methods, Esophageal Neoplasms surgery, Laryngectomy adverse effects, Laryngectomy methods, Pharyngectomy methods, Pharyngectomy adverse effects, Anastomotic Leak epidemiology, Anastomotic Leak etiology
- Abstract
Background: Second primary esophageal cancer often develops in patients with head and neck cancer, and esophagectomy in patients with a history of total pharyngolaryngectomy (TPL) is challenging. However, the clinical outcomes of these patients have yet to be examined in a multicenter setting., Methods: We evaluated the surgical outcomes of a nationwide cohort of 62 patients who underwent esophagectomy for esophageal cancer with a history of TPL., Results: Ivor-Lewis and McKeown esophagectomies were performed in 32 (51.6%) and 30 (48.4%) patients, respectively. Postoperatively, 23 patients (37.1%) developed severe complications, and 7 patients (11.3%) required reoperation within 30 days. Pneumonia and anastomotic leakage occurred in 13 (21.0%) and 16 (25.8%) patients, respectively. Anastomotic leakage occurred more frequently in the McKeown group than in the Ivor-Lewis group (46.7% vs. 6.2%, P < 0.001). The adjusted odds ratio for anastomotic leakage in the McKeown group was 9.64 (95% confidence intervals (CI), 2.11-70.82, P = 0.008). Meanwhile, the 5-year overall survival rates were comparable between the groups (41.8% for Ivor-Lewis and 42.7% for McKeown), and the adjusted hazard ratio of overall survival was 1.44 (95% CI, 0.64-3.29; P = 0.381; Ivor-Lewis as the reference)., Conclusions: In our cohort, anastomotic leakage occurred more frequently after McKeown than Ivor-Lewis esophagectomy, and almost half of patients in the McKeown group experienced leakage. Ivor-Lewis esophagectomy is preferred for decreasing anastomotic leakage when oncologically and technically feasible., (© 2024. The Author(s) under exclusive licence to The Japan Esophageal Society.)
- Published
- 2024
- Full Text
- View/download PDF
17. Impact of Diagnosis and Treatment of Chronic Endometritis on Outcomes Before Starting Assisted Reproductive Technology: A Retrospective Study.
- Author
-
Sakai K, Takehara I, Kaneko H, Nakamura F, Nakai N, Takahashi K, Matsukawa J, Matsuo K, and Nagase S
- Subjects
- Humans, Female, Retrospective Studies, Adult, Pregnancy, Chronic Disease, Pregnancy Rate, Treatment Outcome, Embryo Implantation, Embryo Transfer, Infertility, Female therapy, Infertility, Female diagnosis, Endometritis diagnosis, Endometritis therapy, Endometritis drug therapy, Reproductive Techniques, Assisted
- Abstract
This study aimed to investigate the effect of diagnosis and treatment of chronic endometritis (CE) on the outcome of assisted reproductive technology (ART) with or without repeated implantation failure (RIF). This retrospective analysis included patients who underwent pathological examination for diagnosis of CE at Yamagata University Hospital. The examination was performed for all patients planned for ART with or without RIF. Patients who were examined within 6 months of the first oocyte retrieval or embryo transfer were included. We counted the number of CD138-positive cells within the endometrial stroma in patients' specimens and analyzed the patients' clinical information. Clinical rates of pregnancy and implantation were determined. A total of 80 women met the inclusion criteria: 13 CE-negative patients (17.3%) and 67 CE-positive patients (83.7%). A significant decrease was noted in the CD138-positive cell count between the first biopsy and second biopsy after CE treatment (p < 0.001). In addition, no significant differences were noted in ongoing pregnancy rates between the CE-negative patients and those who underwent CE treatment. The CD138-positive cell counts at first biopsy tended to be lower in each pregnancy group than in the non-pregnancy group. For patients planned to undergo ART, examination for diagnosis of CE with or without RIF could be considered. Pathological CD138-positive cell counts were considered useful for CE diagnosis and treatment decision-making. The study findings suggest the efficacy of antimicrobial agents in CE treatment, contributing to improved pregnancy outcomes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
18. Identifying Pregnant Patients With Suspected Intimate Partner Violence.
- Author
-
McGing M, Ashbrook M, Cheng V, Matsuo K, Schellenberg M, Martin M, Inaba K, and Matsushima K
- Subjects
- Humans, Female, Pregnancy, Adult, United States epidemiology, Young Adult, Retrospective Studies, Wounds and Injuries epidemiology, Risk Factors, Substance-Related Disorders epidemiology, Facial Injuries epidemiology, Pregnancy Complications epidemiology, Intimate Partner Violence statistics & numerical data
- Abstract
Introduction: Intimate partner violence (IPV) is the leading cause of death in pregnant women. Although it can be difficult to identify patients experiencing IPV, injuries to the head, neck, or face due to an assault are known to correlate with intentional injury. The objective of this study is to assess the contemporary burden of IPV in pregnancy and describe the patient characteristics., Methods: The National Inpatient Sample was queried for all pregnant women between January 2016 and December 2019. Patients were divided into two groups: suspected IPV (SIPV) and no-SIPV groups. We defined SIPV as any pregnant patient with an identified head, neck, or face injuries categorized as intentional assault. Multivariable logistic regression analysis was performed to assess the association between SIPV and variables of interest., Results: A total of 28,540 pregnant patients presented with traumatic injuries with 530 (.02%) identified as SIPV. Suspected IPV patients were younger (25 vs 27 years, P = .012), more likely to be of Black race (46% vs 28%, P = .002), more likely to be in the lowest income quartile (51% vs 38%, P = .031), less likely to have private insurance (12% vs 34%, P < .001), and have higher rates of substance use disorder (35% vs 18%, P < .001). Black race and history of substance use disorder were associated with increased odds of SIPV-related injuries (odds ratio [OR]: 2.01, interquartile range [IQR]: 1.27-3.16, P = .003 and OR: 2.30, IQR 1.54-3.43, P < .001, respectively)., Conclusions: Our results suggest that there are significant racial and socioeconomic disparities in potential risk for IPV during pregnancy., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
19. Chordoma cells possess bone-dissolving activity at the bone invasion front.
- Author
-
Kawaai K, Oishi Y, Kuroda Y, Tamura R, Toda M, and Matsuo K
- Subjects
- Humans, Cell Line, Tumor, Male, Female, Middle Aged, Calcium metabolism, Bone and Bones pathology, Aged, Adult, RANK Ligand metabolism, Osteolysis pathology, Neoplasm Invasiveness, Tartrate-Resistant Acid Phosphatase metabolism, Chordoma pathology, Osteoclasts metabolism, Osteoclasts pathology
- Abstract
Purpose: Chordomas are malignant tumors that destroy bones, compress surrounding nerve tissues and exhibit phenotypes that recapitulate notochordal differentiation in the axial skeleton. Chordomas recur frequently, as they resist radio-chemotherapy and are difficult to completely resect, leading to repeated bone destruction and local expansion via unknown mechanisms. Here, using chordoma specimens and JHC7 chordoma cells, we asked whether chordoma cells possess bone-dissolving activity., Methods: CT imaging and histological analysis were performed to evaluate the structure and mineral density of chordoma-invaded bone and osteolytic marker expression. JHC7 cells were subjected to immunocytochemistry, imaging of cell fusion, calcium dynamics and acidic vacuoles, and bone lysis assays., Results: In patients, we found that the skull base invaded by chordoma was highly porous, showed low mineral density and contained brachyury-positive chordoma cells and conventional osteoclasts both expressing the osteolytic markers tartrate-resistant acid phosphatase (TRAP) and collagenases. JHC7 cells expressed TRAP and cathepsin K, became multinucleated via cell-cell fusion, showed spontaneous calcium oscillation, and were partly responsive to the osteoclastogenic cytokine RANKL. JHC7 cells exhibited large acidic vacuoles, and nonregulatory bone degradation without forming actin rings. Finally, bone-derived factors, calcium ions, TGF-β1, and IGF-1 enhanced JHC7 cell proliferation., Conclusion: In chordoma, we propose that in addition to conventional bone resorption by osteoclasts, chordoma cells possess bone-dissolving activity at the tumor-bone boundary. Furthermore, bone destruction and tumor expansion may occur in a positive feedback loop., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia.
- Author
-
Kurosawa S, Fukuda T, Ichinohe T, Hashii Y, Kanda J, Goto H, Kato K, Yoshimitsu M, Ishimaru F, Sato A, Onizuka M, Matsuo K, Ito Y, Yanagisawa A, Ohbiki M, Tabuch K, Atsuta Y, and Arai Y
- Subjects
- Humans, Adult, Male, Female, Middle Aged, Retrospective Studies, Adolescent, Young Adult, Treatment Outcome, Philadelphia Chromosome, Prognosis, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma therapy, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma mortality, Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma mortality, Hematopoietic Stem Cell Transplantation methods, Transplantation, Homologous methods
- Abstract
This nationwide study retrospectively examined the center effect on allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult B-cell acute lymphoblastic leukemia. The cohort analyses were separated into Philadelphia chromosome (Ph)-positive and -negative cases. The patients were divided into low- and high-volume groups according to the number of allo-HSCTs at each facility. The primary endpoint was 5-year overall survival (OS). This study included 1156 low-volume and 1329 high-volume Ph-negative and 855 low-volume and 926 high-volume Ph-positive cases. In Ph-negative cases, 5-year OS was significantly higher in the high-volume centers at 52.7% (95% confidence interval [CI]: 49.9-55.5) versus 46.8% (95% CI: 43.8-49.7) for the low-volume centers (P < 0.01). Multivariate analysis identified high volume as a favorable prognostic factor (hazard ratio [HR]: 0.81 [95% CI: 0.72-0.92], P < 0.01). Subgroup analysis in Ph-negative cases revealed that the center effects were more evident in patients aged ≥40 years (HR: 0.72, 95% CI: 0.61-0.86, P < 0.01) and those receiving cord blood transplantation (HR: 0.62, 95% CI: 0.48-0.79, P < 0.01). In Ph-positive cases, no significant difference was observed between the high and low-volume centers for 5-year OS (59.5% [95% CI: 56.2-62.7] vs. 54.9% [95% CI: 51.3-58.3], P = 0.054). In multivariate analysis, center volume did not emerge as a significant prognostic indicator. This study showed center effects on survival in Ph-negative but not in Ph-positive cases, highlighting the heterogeneity of the center effect in allo-HSCT for B-cell acute lymphoblastic leukemia. Collaborative efforts among transplant centers and further validation are essential to improve outcomes., Competing Interests: Declaration of Competing Interest The authors declare no competing interests., (Copyright © 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. A chemical platform for the efficient screening of arylazopyrazole-based photoswitchable CENP-E inhibitors using mild cyclization reactions.
- Author
-
Matsuo K, Ogawa H, Yamaoka S, Waku T, and Kobori A
- Subjects
- Cyclization, Structure-Activity Relationship, Humans, Molecular Structure, Azo Compounds chemistry, Azo Compounds pharmacology, Azo Compounds chemical synthesis, Dose-Response Relationship, Drug, Pyrazoles chemistry, Pyrazoles pharmacology, Pyrazoles chemical synthesis, Chromosomal Proteins, Non-Histone antagonists & inhibitors, Chromosomal Proteins, Non-Histone metabolism
- Abstract
A set of arylazopyrazole-based inhibitors targeting the mitotic motor protein CENP-E was discovered through the chemical platform using the quantitative cyclization of 1,3-diketone intermediate with various hydrazines under mild conditions. Through this efficient platform, the structure-activity relationship pertaining to the pyrazole photoswitch in photoswitchable CENP-E inhibitors not only in vitro but also in cells was successfully clarified., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
22. Temporal trends of obstetric hemorrhage and product-specific blood transfusion at time of delivery.
- Author
-
Sangara RN, Matsushima K, Matsuzaki S, Yao JA, Yu E, Mandelbaum RS, Grubbs BH, Incerpi MH, Ouzounian JG, and Matsuo K
- Subjects
- Humans, Female, Pregnancy, Delivery, Obstetric, Adult, Time Factors, Postpartum Hemorrhage therapy, Postpartum Hemorrhage epidemiology, Blood Transfusion statistics & numerical data
- Published
- 2024
- Full Text
- View/download PDF
23. Potential Bioactivities, Chemical Composition, and Conformation Studies of Exopolysaccharide-Derived Aspergillus sp. Strain GAD7.
- Author
-
Ibrahim MIA, Ibrahim HAH, Haga T, Ishida A, Nehira T, Matsuo K, and Gad AM
- Abstract
This research identified a marine fungal isolate, Aspergillus sp. strain GAD7, which produces an acidic and sulfated extracellular polysaccharide (EPS) with notable anticoagulant and antioxidant properties. Six fungal strains from the Egyptian Mediterranean Sea were screened for EPS production, with Aspergillus sp. strain GAD7 (EPS-AG7) being the most potent, yielding ~5.19 ± 0.017 g/L. EPS-AG7 was characterized using UV-Vis and FTIR analyses, revealing high carbohydrate (87.5%) and sulfate (24%) contents. HPLC and GC-MS analyses determined that EPS-AG7 is a heterogeneous acidic polysaccharide with an average molecular weight (Mw¯) of ~7.34 × 10
3 Da, composed of mannose, glucose, arabinose, galacturonic acid, galactose, and lyxose in a molar ratio of 6.6:3.9:1.8:1.3:1.1:1.0, linked through α- and β-glycosidic linkages as confirmed by NMR analysis. EPS-AG7 adopted a triple helix-like conformation, as evidenced by UV-Vis (Congo Red experiment) and circular dichroism (CD) studies. This helical arrangement demonstrated stability under various experimental conditions, including concentration, ionic strength, temperature, and lipid interactions. EPS-AG7 exhibited significant anticoagulant activity, doubling blood coagulation time at a concentration of 3.0 mg/mL, and showed significant antioxidant activity, with scavenging activities reaching up to 85.90% and 58.64% in DPPH and ABTS+ assays at 5.0 mg/mL, and EC50 values of 1.40 mg/mL and 3.80 mg/mL, respectively. These findings highlight the potential of EPS-AG7 for therapeutic applications due to its potent biological activities.- Published
- 2024
- Full Text
- View/download PDF
24. Introduction of advanced maternal age based on mortality-specific severe morbidity.
- Author
-
Masjedi AD, Anderson ZS, Pon FF, Matsuzaki S, Mandelbaum RS, Ouzounian JG, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
25. Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.
- Author
-
Inukai M, Nishi T, Matsuoka H, Matsuo K, Suzuki K, Serizawa A, Akimoto S, Nakauchi M, Tanaka T, Kikuchi K, Shibasaki S, Uyama I, and Suda K
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Aged, Neutrophils, Adult, Aged, 80 and over, C-Reactive Protein analysis, Biomarkers, Tumor blood, Blood Platelets pathology, Antineoplastic Agents, Immunological therapeutic use, Lymphocytes, Progression-Free Survival, Lymphocyte Count, Treatment Outcome, ROC Curve, Inflammation blood, Inflammation drug therapy, Nivolumab therapeutic use, Stomach Neoplasms drug therapy, Stomach Neoplasms blood, Stomach Neoplasms mortality, Stomach Neoplasms pathology
- Abstract
Background: Nonresectable gastric cancer develops rapidly; thus, monitoring disease progression especially in patients receiving nivolumab as late-line therapy is important. Biomarkers may facilitate the evaluation of nivolumab treatment response. Herein, we assessed the utility of serum-based inflammatory indicators for evaluating tumor response to nivolumab., Methods: This multicenter retrospective cohort study included 111 patients treated with nivolumab monotherapy for nonresectable advanced or recurrent gastric cancer from October 2017 to October 2021. We measured changes in the C-reactive protein (CRP)-to-albumin ratio (CAR), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) in serum from baseline to after the fourth administration of nivolumab. Furthermore, we calculated the area under the receiver operating characteristic curves (AUC ROCs) for CAR, PLR, and NLR to identify the optimal cutoff values for treatment response. We also investigated the relationship between clinicopathologic factors and disease control (complete response, partial response, and stable disease) using the chi-squared test., Results: The overall response rate (complete and partial response) was 11.7%, and the disease control rate was 44.1%. The median overall survival (OS) was 14.0 (95% CI 10.7‒19.2) months, and the median progression-free survival (PFS) was 4.1 (95% CI 3.0‒5.9) months. The AUC ROCs for CAR, PLR, and NLR before nivolumab monotherapy for patients with progressive disease (PD) were 0.574 (95% CI, 0.461‒0.687), 0.528 (95% CI, 0.418‒0.637), and 0.511 (95% CI, 0.401‒0.620), respectively. The values for changes in CAR, PLR, and NLR were 0.766 (95% CI, 0.666‒0.865), 0.707 (95% CI, 0.607‒0.807), and 0.660 (95% CI 0.556‒0.765), respectively. The cutoff values for the treatment response were 3.0, 1.3, and 1.4 for CAR, PLR, and NLR, respectively. The PFS and OS were significantly longer when the treatment response values for changes in CAR, PLR, and NLR were below these cutoff values (CAR: OS, p < 0.0001 and PFS, p < 0.0001; PLR: OS, p = 0.0289 and PFS, p = 0.0302; and NLR: OS, p = 0.0077 and PFS, p = 0.0044)., Conclusions: Measurement of the changes in CAR, PLR, and NLR could provide a simple, prompt, noninvasive method to evaluate response to nivolumab monotherapy., Trial Registration: This study is registered with number K2023006., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. Assessment of early-death in gynecologic malignancy in the United States.
- Author
-
Vallejo A, Lee MW, Klar M, Wright JD, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
27. Considerations for route of hysterectomy in low-risk cervical cancer.
- Author
-
Guo XM, Roman LD, and Matsuo K
- Subjects
- Humans, Female, Uterine Cervical Neoplasms surgery, Uterine Cervical Neoplasms pathology, Hysterectomy methods
- Abstract
Competing Interests: Competing interests: LDR reports consulting for Cardiff Oncology, Nutcracker Therapeutics, and AXDEV as well as participation in the Steering Committee for the Global Coalition of Adaptive Research. The remaining authors do not report any relevant conflicts of interest. All authors guarantee the manuscript.
- Published
- 2024
- Full Text
- View/download PDF
28. Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer.
- Author
-
Matsuo K, Shimada M, Matsuzaki S, Machida H, Shigeta S, Yoshida H, Kato K, Kanao H, Takekuma M, Mikami M, and Okamoto A
- Subjects
- Humans, Female, Retrospective Studies, Middle Aged, Adult, Aged, Lymph Node Excision, Cohort Studies, Neoplasm Recurrence, Local pathology, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms therapy, Hysterectomy, Neoplasm Staging, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Carcinoma, Squamous Cell surgery
- Abstract
Objective: The objective of this study was to assess the oncologic outcome of surgically-treated patients with early-stage, intermediate-risk cervical cancer according to postoperative therapy modality., Methods: This retrospective cohort study queried the Japanese Gynecologic Oncology Group's nationwide surgical data platform. The study population was 1084 patients with stage IB cervical cancer who underwent primary radical hysterectomy and lymphadenectomy from 2004 to 2008. Histology type-incorporated intermediate-risk factor patterns were clustered into three groups based on recurrence risk. Oncologic outcomes were assessed per postoperative therapy: external beam radiotherapy alone, concurrent chemo-radiotherapy, chemotherapy alone, and no treatment., Results: Histology-incorporated intermediate-risk groups included: no lympho-vascular space invasion in any histology, or squamous cell carcinoma with lympho-vascular space invasion but no deep stromal invasion (n=559, 51.6%, group 1); squamous cell carcinoma with both lympho-vascular space invasion and deep cervical stromal invasion (n=281, 25.9%; group 2); and non-squamous histology with lympho-vascular space invasion (n=244, 22.5%; group 3). The 5-year disease-free survival rates were 93.3%, 89.3%, and 82.5% for group 1,-2, and -3, respectively (p<0.001), with group 3 exhibiting an almost three-fold increased recurrence risk compared with group 1 (adjusted-hazard ratio (aHR) 2.70, 95% confidence interval (CI) 1.70-4.32), followed by group 2 (aHR 1.67, 95% CI 1.01 to 2.75). Disease-free survival was similar across the postoperative therapy groups: 5 year rates for external beam radiotherapy alone, concurrent chemo-radiotherapy, chemotherapy alone, and no postoperative treatment, 94.8%, 87.2%, 93.6%, and 94.2% for group 1 (p=0.294); 85.0%, 93.3%, 87.3%, and 90.5% for group 2 (p=0.578); and 85.4%, 83.1%, 80.5%, and 83.3% for group 3 (p=0.876). The aHR for disease-free survival comparing no postoperative treatment to external beam radiotherapy alone was 1.10 (95% CI 0.37 to 3.28), 0.71 (95% CI 0.29 to 1.79), and 1.21 (95% CI 0.42 to 3.51) for group 1, group 2, and group 3, respectively. The observed exposure-outcome associations were similar for cause-specific survival (all, p>0.05)., Conclusion: In this retrospective investigation in Japan, active surveillance without postoperative therapy following radical hysterectomy and lymphadenectomy was not associated with oncologic outcome in early-stage, intermediate-risk cervical cancer., Competing Interests: Competing interests: Research grant, Bristol Myers Squibb, honorarium, AstraZenaca (MH); none for the other authors., (© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
29. Developing long bones respond to surrounding tissues by trans-pairing of periosteal osteoclasts and endocortical osteoblasts.
- Author
-
Kuroda Y, Yoda M, Kawaai K, Tatenuma M, Mizoguchi T, Ito S, Kasahara M, Wu Y, Takano H, Momose A, and Matsuo K
- Subjects
- Animals, Mice, Bone Development, Osteogenesis physiology, Bone Resorption pathology, Cortical Bone, RANK Ligand metabolism, Mice, Inbred C57BL, Osteoblasts metabolism, Osteoblasts cytology, Periosteum cytology, Periosteum metabolism, Osteoclasts metabolism, Osteoclasts cytology
- Abstract
Developing long bones alter their shape while maintaining uniform cortical thickness via coordinated activity of bone-forming osteoblasts and bone-resorbing osteoclasts at periosteal and endosteal surfaces, a process we designate trans-pairing. Two types of trans-pairing shift cortical bone in opposite orientations: peri-forming trans-pairing (peri-t-p) increases bone marrow space and endo-forming trans-pairing (endo-t-p) decreases it, via paired activity of bone resorption and formation across the cortex. Here, we focused on endo-t-p in growing bones. Analysis of endo-t-p activity in the cortex of mouse fibulae revealed osteoclasts under the periosteum compressed by muscles, and expression of RANKL in periosteal cells of the cambium layer. Furthermore, mature osteoblasts were localized on the endosteum, while preosteoblasts were at the periosteum and within cortical canals. X-ray tomographic microscopy revealed the presence of cortical canals more closely associated with endo- than with peri-t-p. Sciatic nerve transection followed by muscle atrophy and unloading induced circumferential endo-t-p with concomitant spread of cortical canals. Such canals likely supply the endosteum with preosteoblasts from the periosteum under endo-t-p, allowing bone shape to change in response to mechanical stress or nerve injury., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2024. Published by The Company of Biologists Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
30. What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?
- Author
-
Kikuta S, Abe Y, Hino K, Imai S, Matsuo K, Shinozaki K, Nakamura M, Seki N, and Kusukawa J
- Subjects
- Humans, Male, Retrospective Studies, Female, Middle Aged, Prognosis, Aged, Adult, Neoplasm Metastasis, Aged, 80 and over, Treatment Outcome, Immune Checkpoint Inhibitors therapeutic use, Mouth Neoplasms drug therapy, Mouth Neoplasms pathology, Mouth Neoplasms diagnosis, Nivolumab therapeutic use, Antibodies, Monoclonal, Humanized administration & dosage, Antibodies, Monoclonal, Humanized therapeutic use, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local epidemiology, Neoplasm Recurrence, Local diagnosis
- Abstract
Background: Immune checkpoint inhibitors (ICIs) are widely adapted for recurrent or metastatic head and neck cancer (RM-HNC), and various studies on its prognostic factors have been reported. We aimed to elucidate the prognostic factors of ICI treatment for RM oral cancer (RM-OC) in a retrospective study., Methods: We retrospectively reviewed patients with RM-OC treated with ICIs (nivolumab and pembrolizumab) at our department from May 2017 to February 2023. The objective response rate (ORR) for ICI treatment and the relationship between several potential prognostic factors, progression-free survival (PFS), and overall survival (OS) were analyzed statistically., Results: The investigation enrolled 31 patients, 16 with nivolumab and 15 with pembrolizumab. There were no significant differences in the ORR or disease control rate between the nivolumab and pembrolizumab groups (p = 0.4578 and 0.2524). In multivariate analysis, the prognostic nutritional index (PNI) and C-reactive protein to albumin ratio (CAR) exhibited statistical correlations with PFS, whereas the use of antibiotics and proton pump inhibitors (PPIs), neutrophil to lymphocyte ratio (NLR), and PNI demonstrated statistical associations with OS., Conclusion: Our findings imply that the use of antibiotics and PPIs, which can modify the gut microbiota, may also serve as a prognostic determinant for ICI treatment in RM-OC, consistent with previous studies. Additionally, PNI may be essential in affecting the survival rates of both PFS and OS and could be an exceedingly valuable inflammatory biomarker for RM-OC., Competing Interests: Declaration of competing interest None declared., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan.
- Author
-
Machida H, Matsuo K, Higashi T, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, and Mikami M
- Subjects
- Humans, Female, Japan, Hospitals, Low-Volume statistics & numerical data, Hospitals, Low-Volume economics, Decision Support Techniques, Middle Aged, Aged, Cost-Effectiveness Analysis, Endometrial Neoplasms economics, Endometrial Neoplasms therapy, Endometrial Neoplasms mortality, Endometrial Neoplasms pathology, Cost-Benefit Analysis, Hospitals, High-Volume statistics & numerical data, Quality-Adjusted Life Years
- Abstract
Objective: Hospital treatment volume affects survival in patients with endometrial cancer; notably, initial treatment at high-volume centers improves survival outcomes. Our study assessed the effect of hospital treatment volume on cost-effectiveness and survival outcomes in patients with endometrial cancer in Japan., Methods: A decision-analytic model was evaluated using the following variables and their impact on cost-effectiveness: 1) hospital treatment volume (low-, intermediate-, and high-volume centers) and 2) postoperative recurrent risk factors based on pathological findings (high- and intermediate-risk or low-risk). Data were obtained from the Japan Society of Obstetrics and Gynecology database, systematic literature searches, and the Japanese Diagnosis Procedure Combination database. Quality-adjusted life years (QALY) was used as a measure of effectiveness. The model was built from a public healthcare perspective and the impact of uncertainty was assessed using sensitivity analyses., Results: A base-case analysis showed that the incremental cost-effectiveness ratio at high-volume centers was below a willingness-to-pay (WTP) threshold of ¥5,000,000 with a maximum of ¥3,777,830/4.28 QALY for the high- and intermediate-risk group, and ¥2,316,695/4.57 QALY for the low-risk group. Treatment at the high-volume centers showed better efficiency and cost-effectiveness in both strategies compared to intermediate- or low-volume centers. Sensitivity analyses showed that the model outcome was robust to changes in input values. With the WTP threshold, treatment at high-volume centers remained cost-effective in at least 73.6% and 78.2% of iterations for high- and intermediate-risk, and low-risk groups, respectively., Conclusion: Treatment at high-volume centers is the most cost-effective strategy for guiding treatment centralization in patients with endometrial cancer., Competing Interests: Honorarium, Bristol Myers Squibb (H.M) and none for others., (© 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
32. Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population.
- Author
-
Fujii R, Hishida A, Nakatochi M, Okumiyama H, Takashima N, Tsuboi Y, Suzuki K, Ikezaki H, Shimanoe C, Kato Y, Tamura T, Ito H, Michihata N, Tanoue S, Suzuki S, Kuriki K, Kadota A, Watanabe T, Momozawa Y, Wakai K, and Matsuo K
- Subjects
- Humans, Female, Male, Middle Aged, Japan epidemiology, Prospective Studies, Aged, Adult, Risk Factors, Multifactorial Inheritance, Hypertension genetics, Cohort Studies, Genetic Risk Score, East Asian People, Cardiovascular Diseases mortality, Cardiovascular Diseases genetics, Life Style, Blood Pressure genetics
- Abstract
Although previous polygenic risk score (PRS) studies for cardiovascular disease (CVD) focused on incidence, few studies addressed CVD mortality and quantified risks by environmental exposures in different genetic liability groups. This prospective study aimed to examine the associations of blood pressure PRS with all-cause and CVD mortality and to quantify the attributable risk by modifiable lifestyles across different PRS strata. 9,296 participants in the Japan Multi-Institutional Collaborative Cohort Study without hypertension at baseline were analyzed in this analysis. PRS for systolic blood pressure and diastolic blood pressure (PRS
SBP and PRSDBP ) were developed using publicly available Biobank Japan GWAS summary statistics. CVD-related mortality was defined by the International Classification of Diseases 10th version (I00-I99). Cox-proportional hazard model was used to examine associations of PRSs and lifestyle variables (smoking, drinking, and dietary sodium intake) with mortality. During a median 12.6-year follow-up period, we observed 273 all-cause and 41 CVD mortality cases. Compared to the middle PRS group (20-80th percentile), adjusted hazard ratios for CVD mortality at the top PRS group ( > 90th percentile) were 3.67 for PRSSBP and 2.92 for PRSDBP . Attributable risks of CVD mortality by modifiable lifestyles were higher in the high PRS group ( > 80th percentile) compared with the low PRS group (0-80th percentile). In summary, blood pressure PRS is associated with CVD mortality in the general Japanese population. Our study implies that integrating PRS with lifestyle could contribute to identify target populations for lifestyle intervention even though improvement of discriminatory ability by PRS alone is limited., (© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)- Published
- 2024
- Full Text
- View/download PDF
33. Improvement of the temporomandibular joint symptoms due to the condylar position change following modified L-shaped intraoral vertico-sagittal ramus osteotomy: a single-center, retrospective study.
- Author
-
Kikuta S, Matsuo K, Abe Y, Iwanaga J, and Kusukawa J
- Subjects
- Humans, Retrospective Studies, Male, Female, Adult, Young Adult, Middle Aged, Cephalometry, Temporomandibular Joint surgery, Temporomandibular Joint diagnostic imaging, Imaging, Three-Dimensional, Adolescent, Mandibular Condyle surgery, Mandibular Condyle diagnostic imaging, Osteotomy, Sagittal Split Ramus methods, Temporomandibular Joint Disorders surgery, Temporomandibular Joint Disorders diagnostic imaging, Cone-Beam Computed Tomography
- Abstract
Purpose: Intraoral vertico-sagittal ramus osteotomy (IVSRO) was first reported by Choung in 1992 as a surgical procedure to decrease postoperative condylar dislocation. In 2017, Iwanaga et al. developed modified L-shaped IVSRO (mIVSRO) to reduce postoperative nerve dysfunction and achieved favorable outcomes. This study aimed to clarify the effect of mIVSRO on changes in temporomandibular joint (TMJ) symptoms and three-dimensional condylar position., Methods: We conducted a retrospective study of thirty sides in fifteen Japanese adults diagnosed with jaw deformities who underwent mIVSRO and sagittal split ramus osteotomy (SSRO). TMJ symptoms were assessed chronologically, and the condylar long axis and the condylar position were analyzed two- and three-dimensionally using axial cephalograms and cone-beam computed tomography., Results: Postoperative TMJ symptoms improved by 90% (9/10 sides) in the mIVSRO group and by 50% (7/14 sides) in the SSRO group. The mIVSRO group exhibited outward rotation of the condylar long axis, while the SSRO group exhibited inward rotation. Moreover, mIVSRO induced residual anteromedial-inferior deviation of the condyle. The inclination angle of the condylar process was not significantly different between the two procedures pre- and postoperatively., Conclusion: These results clearly demonstrated the effect of mIVSRO on symptomatic TMJ. Residual changes in the position of the condyle following mIVSRO may not affect jaw function., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
34. Super-resolution deep learning reconstruction approach for enhanced visualization in lumbar spine MR bone imaging.
- Author
-
Hokamura M, Nakaura T, Yoshida N, Uetani H, Shiraishi K, Kobayashi N, Matsuo K, Morita K, Nagayama Y, Kidoh M, Yamashita Y, Miyamoto T, and Hirai T
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Aged, Adult, Signal-To-Noise Ratio, Imaging, Three-Dimensional methods, Aged, 80 and over, Spinal Diseases diagnostic imaging, Deep Learning, Lumbar Vertebrae diagnostic imaging, Magnetic Resonance Imaging methods
- Abstract
Objectives: This study aims to assess the effectiveness of super-resolution deep-learning-based reconstruction (SR-DLR), which leverages k-space data, on the image quality of lumbar spine magnetic resonance (MR) bone imaging using a 3D multi-echo in-phase sequence., Materials and Methods: In this retrospective study, 29 patients who underwent lumbar spine MRI, including an MR bone imaging sequence between January and April 2023, were analyzed. Images were reconstructed with and without SR-DLR (Matrix sizes: 960 × 960 and 320 × 320, respectively). The signal-to-noise ratio (SNR) of the vertebral body and spinal canal and the contrast and contrast-to-noise ratio (CNR) between the vertebral body and spinal canal were quantitatively evaluated. Furthermore, the slope at half-peak points of the profile curve drawn across the posterior border of the vertebral body was calculated. Two radiologists independently assessed image noise, contrast, artifacts, sharpness, and overall image quality of both image types using a 4-point scale. Interobserver agreement was evaluated using weighted kappa coefficients, and quantitative and qualitative scores were compared via the Wilcoxon signed-rank test., Results: SNRs of the vertebral body and spinal canal were notably improved in images with SR-DLR (p < 0.001). Contrast and CNR were significantly enhanced with SR-DLR compared to those without SR-DLR (p = 0.023 and p = 0.022, respectively). The slope of the profile curve at half-peak points across the posterior border of the vertebral body and spinal canal was markedly higher with SR-DLR (p < 0.001). Qualitative scores (noise: p < 0.001, contrast: p < 0.001, artifact p = 0.042, sharpness: p < 0.001, overall image quality: p < 0.001) were superior in images with SR-DLR compared to those without. Kappa analysis indicated moderate to good agreement (noise: κ = 0.56, contrast: κ = 0.51, artifact: κ = 0.46, sharpness: κ = 0.76, overall image quality: κ = 0.44)., Conclusion: SR-DLR, which is based on k-space data, has the potential to enhance the image quality of lumbar spine MR bone imaging utilizing a 3D gradient echo in-phase sequence., Clinical Relevance Statement: The application of SR-DLR can lead to improvements in lumbar spine MR bone imaging quality., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models.
- Author
-
Matsuo K and Nshihara H
- Abstract
The blood-brain barrier is a unique function of the microvasculature in the brain parenchyma that maintains homeostasis in the central nervous system. Blood-brain barrier breakdown is a common pathology in various neurological diseases, such as Alzheimer's disease, stroke, multiple sclerosis, and Parkinson's disease. Traditionally, it has been considered a consequence of neuroinflammation or neurodegeneration, but recent advanced imaging techniques and detailed studies in animal models show that blood-brain barrier breakdown occurs early in the disease process and may precede neuronal loss. Thus, the blood-brain barrier is attractive as a potential therapeutic target for neurological diseases that lack effective therapeutics. To elucidate the molecular mechanism underlying blood-brain barrier breakdown and translate them into therapeutic strategies for neurological diseases, there is a growing demand for experimental models of human origin that allow for functional assessments. Recently, several human induced pluripotent stem cell-derived blood-brain barrier models have been established and various in vitro blood-brain barrier models using microdevices have been proposed. Especially in the Alzheimer's disease field, the human evidence for blood-brain barrier dysfunction has been demonstrated and human induced pluripotent stem cell-derived blood-brain barrier models have suggested the putative molecular mechanisms of pathological blood-brain barrier. In this review, we summarize recent evidence of blood-brain barrier dysfunction in Alzheimer's disease from pathological analyses, imaging studies, animal models, and stem cell sources. Additionally, we discuss the potential future directions for blood-brain barrier research., (Copyright © 2024 Copyright: © 2024 Neural Regeneration Research.)
- Published
- 2024
- Full Text
- View/download PDF
36. Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data.
- Author
-
Kuwatsuka Y, Ito H, Tabuchi K, Konuma T, Uchida N, Inamoto Y, Inai K, Nishida T, Ikegame K, Eto T, Katayama Y, Kataoka K, Tanaka M, Takahashi S, Fukuda T, Ichinohe T, Kimura F, Kanda J, Atsuta Y, and Matsuo K
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Adolescent, Child, Child, Preschool, Survival Rate, Infant, Aged, Young Adult, Transplantation, Homologous, Japan epidemiology, Allografts, Hematopoietic Stem Cell Transplantation mortality, Hematopoietic Stem Cell Transplantation methods, Registries
- Abstract
Prognosis for patients undergoing hematopoietic cell transplantation (HCT) has been improving. Short-term survival information, such as crude survival rates that consider deaths immediately after the transplantation, may not be sufficiently useful for assessing long-term survival. Using the data of the Japanese HCT registry, the net survival rate of patients who survived for a given period was determined according to age, disease, and type of transplant. We included a total of 41,716 patients who received their first allogeneic hematopoietic cell transplantation between 1991 and 2015. For each disease, age group, graft source subcategory, net survival was calculated using the Pohar-Perme method, and 5-year conditional net survival (CS) was calculated. Ten-year net survivals of total patient cohort were 41.5% and 47.4% for males and females, respectively. Except for myelodysplastic syndrome, multiple myeloma, and adult T-cell leukemia/lymphoma, 5-year CS for 5-year transplant survivors exceeded 90%. CS was especially high for aplastic anemia, of which was over 100% for children and younger adults receiving cord blood, suggesting that these patients have similar longevity to an equivalent group from the general population. These findings provide useful information for long-term survival, and can serve as benchmark for comparisons among registries, including other cancers., (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2024
- Full Text
- View/download PDF
37. Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium.
- Author
-
Ho NT, Abe SK, Rahman MS, Islam R, Saito E, Gupta PC, Pednekar MS, Sawada N, Tsugane S, Tamakoshi A, Kimura T, Shu XO, Gao YT, Koh WP, Cai H, Wen W, Sakata R, Tsuji I, Malekzadeh R, Pourshams A, Kanemura S, Kim J, Chen Y, Ito H, Oze I, Nagata C, Wada K, Sugawara Y, Park SK, Shin A, Yuan JM, Wang R, Kweon SS, Shin MH, Poustchi H, Vardanjani HM, Ahsan H, Chia KS, Matsuo K, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D, and Boffetta P
- Subjects
- Humans, Incidence, Asia epidemiology, Male, Female, Adult, Middle Aged, Cohort Studies, Diabetes Mellitus epidemiology, Diabetes Mellitus mortality, Risk Factors, Proportional Hazards Models, Aged, Liver Neoplasms epidemiology, Liver Neoplasms mortality
- Abstract
There has been growing evidence suggesting that diabetes may be associated with increased liver cancer risk. However, studies conducted in Asian countries are limited. This project considered data of 968,738 adults pooled from 20 cohort studies of Asia Cohort Consortium to examine the association between baseline diabetes and liver cancer incidence and mortality. Cox proportional hazard model and competing risk approach was used for pooled data. Two-stage meta-analysis across studies was also done. There were 839,194 subjects with valid data regarding liver cancer incidence (5654 liver cancer cases [48.29/100,000 person-years]), follow-up time and baseline diabetes (44,781 with diabetes [5.3%]). There were 747,198 subjects with valid data regarding liver cancer mortality (5020 liver cancer deaths [44.03/100,000 person-years]), follow-up time and baseline diabetes (43,243 with diabetes [5.8%]). Hazard ratio (HR) (95% confidence interval [95%CI]) of liver cancer diagnosis in those with vs. without baseline diabetes was 1.97 (1.79, 2.16) (p < .0001) after adjusting for baseline age, gender, body mass index, tobacco smoking, alcohol use, and heterogeneity across studies (n = 586,072; events = 4620). Baseline diabetes was associated with increased cumulative incidence of death due to liver cancer (adjusted HR (95%CI) = 1.97 (1.79, 2.18); p < .0001) (n = 595,193; events = 4110). A two-stage meta-analytic approach showed similar results. This paper adds important population-based evidence to current literature regarding the increased incidence and mortality of liver cancer in adults with diabetes. The analysis of data pooled from 20 studies of different Asian countries and the meta-analysis across studies with large number of subjects makes the results robust., (© 2024 UICC.)
- Published
- 2024
- Full Text
- View/download PDF
38. Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).
- Author
-
Hatori M, Tsuji D, Suzuki K, Yokokawa T, Kawakami K, Moriyama R, Osada-Tsuchiya M, Otake A, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Sasahira N, Ishii H, Yamaguchi M, and Itoh K
- Subjects
- Humans, Female, Male, Aged, Prospective Studies, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Ribonucleoside Diphosphate Reductase genetics, Antimetabolites, Antineoplastic therapeutic use, Aged, 80 and over, Paclitaxel therapeutic use, Paclitaxel administration & dosage, Adult, Neoplasm Metastasis, Equilibrative Nucleoside Transporter 1 genetics, Treatment Outcome, Pharmacogenomic Testing, Genotype, Gemcitabine, Deoxycytidine analogs & derivatives, Deoxycytidine therapeutic use, Deoxycytidine administration & dosage, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms genetics, Pancreatic Neoplasms pathology, Pancreatic Neoplasms mortality, CA-19-9 Antigen blood
- Abstract
Background: Genetic polymorphisms of molecules are known to cause individual differences in the therapeutic efficacy of anticancer drugs. However, to date, germline mutations (but not somatic mutations) for anticancer drugs have not been adequately studied. The objective of this study was to investigate the association between germline polymorphisms of gemcitabine metabolic and transporter genes with carbohydrate antigen 19-9 (CA 19-9) response (decrease ≥50% from the pretreatment level at 8 weeks) and overall survival (OS) in patients with metastatic pancreatic cancer who receive gemcitabine-based chemotherapy., Methods: This multicenter, prospective, observational study enrolled patients with metastatic pancreatic cancer patients who were receiving gemcitabine monotherapy or gemcitabine plus nanoparticle albumin-bound paclitaxel combination chemotherapy. Thirteen polymorphisms that may be involved in gemcitabine responsiveness were genotyped, and univariate and multivariate logistic regression analyses were used to determine the association of these genotypes with CA 19-9 response and OS. The significance level was set at 5%., Results: In total, 180 patients from 11 hospitals in Japan were registered, and 159 patients whose CA 19-9 response could be assessed were included in the final analysis. Patients who had a CA 19-9 response had significantly longer OS (372 vs. 241 days; p = .007). RRM1 2464A>G and RRM2 175T>G polymorphisms suggested a weak association with CA 19-9 response and OS, but it was not statistically significant. COX-2 -765G>C polymorphism did not significantly correlate with CA 19-9 response but was significantly associated with OS (hazard ratio, 2.031; p = .019)., Conclusions: Genetic polymorphisms from the pharmacokinetics of gemcitabine did not indicate a significant association with efficacy, but COX-2 polymorphisms involved in tumor cell proliferation might affect OS., (© 2024 American Cancer Society.)
- Published
- 2024
- Full Text
- View/download PDF
39. Impact of Hospital Dentistry on Patients' Food Intake Status in Convalescent Rehabilitation Ward.
- Author
-
Ohno T, Terada I, Nomoto A, Fujishima I, Iwasa Y, Umeda Y, Kanamori D, Kishima M, Sakaguchi H, Matsuo K, Motohashi Y, Ozaki K, and Minakuchi S
- Abstract
Background: Treating oral problems with dentist intervention during hospitalisation may improve patients' food intake status., Objectives: This study aimed to clarify whether convalescent rehabilitation ward inpatients in a hospital with hospital dentistry (HHD) had a better diet at discharge than those in a hospital without hospital dentistry (HNHD)., Methods: Retrospective observational study including inpatients with dental involvement in a HHD with dentists and dental hygienists and HNHD with dental hygienist and visiting dental service between 1 March and 31 August 2022. Data included age, sex, body mass index (BMI), Functional Independent Measure (FIM) motor and cognitive, Oral Health Assessment Tool (OHAT) score, Food Intake LEVEL Scale (FILS), whether the FILS ≥8 (indicating that patient eats also a non-texture-modified diet), remained and functional tooth numbers and speech language hearing therapist (SLHT) and dentist interventions. Comparisons between the two hospitals and factors that affected the FILS ≥8 were examined., Results: A total of 333 and 89 inpatients were included in the HHD and HNHD groups, respectively. After propensity score matching, the HHD group had a significantly higher rate of FILS ≥8, functional tooth numbers at discharge, and SLHT and dentist intervention rates. The multivariable logistic regression analysis for propensity score matching participants showed that the significant independent variables for FILS ≥8 were age, BMI, FILS, FIM motor (all at admission) and SLHT and dentist interventions. Odds ratio for dentist intervention was 14.46 (95% CI: 4.36-48.01)., Conclusions: Dentists are necessary to improve patients' food intake status in convalescent rehabilitation wards., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
40. Comprehensive serum glycopeptide spectra analysis to identify early-stage epithelial ovarian cancer.
- Author
-
Mikami M, Tanabe K, Imanishi T, Ikeda M, Hirasawa T, Yasaka M, Machida H, Yoshida H, Hasegawa M, Shimada M, Kato T, Kitamura S, Kato H, Fujii T, Kobayashi Y, Suzuki N, Tanaka K, Murakami I, Katahira T, Hayashi C, and Matsuo K
- Subjects
- Humans, Female, Middle Aged, ROC Curve, CA-125 Antigen blood, Neoplasm Staging, Adult, Aged, Chromatography, Liquid methods, Early Detection of Cancer methods, Case-Control Studies, WAP Four-Disulfide Core Domain Protein 2 analysis, WAP Four-Disulfide Core Domain Protein 2 metabolism, Carcinoma, Ovarian Epithelial blood, Carcinoma, Ovarian Epithelial diagnosis, Carcinoma, Ovarian Epithelial pathology, Biomarkers, Tumor blood, Ovarian Neoplasms blood, Ovarian Neoplasms diagnosis, Ovarian Neoplasms pathology, Glycopeptides blood
- Abstract
Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new method, named Comprehensive Serum Glycopeptide Spectral Analysis (CSGSA), which detects early-stage cancer by combining glycan alterations in serum glycoproteins with tumor markers. We detected 1712 glycopeptides using liquid chromatography-mass spectrometry from the sera obtained from 564 patients with EOC and 1149 controls across 13 institutions. Furthermore, we used a convolutional neural network to analyze the expression patterns of the glycopeptides and tumor markers. Using this approach, we successfully differentiated early-stage EOC (Stage I) from non-EOC, with an area under the curve (AUC) of 0.924 in receiver operating characteristic (ROC) analysis. This method markedly outperforms conventional tumor markers, including cancer antigen 125 (CA125, 0.842) and human epididymis protein 4 (HE4, 0.717). Notably, our method exhibited remarkable efficacy in differentiating early-stage ovarian clear cell carcinoma from endometrioma, achieving a ROC-AUC of 0.808, outperforming CA125 (0.538) and HE4 (0.557). Our study presents a promising breakthrough in the early detection of EOC through the innovative CSGSA method. The integration of glycan alterations with cancer-related tumor markers has demonstrated exceptional diagnostic potential., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
41. Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders).
- Author
-
Kato T, Ogasawara K, Motomura K, Kato M, Tanaka T, Takaesu Y, Nio S, Kishi T, So M, Nemoto K, Suzuki E, Watanabe K, and Matsuo K
- Abstract
The Japanese Society of Mood Disorders (JSMD) published treatment guidelines of bipolar disorder in 2011. The present guidelines incorporating new findings were developed to comply to the guidelines of the National Academy of Medicine (NAM) by utilizing systematic reviews and meta-analysis and taking patient and family opinions as well as insights from multiple professional fields into account. They support combination therapy using mood stabilizers and second-generation antipsychotics in many aspects. They also have limitations, including the grouping of mood stabilizers and second-generation antipsychotics when meta-analysis was performed despite their distinct properties, due to the scarcity of drug-specific evidence. Despite the limitations, these guidelines provide clinical decision support for psychiatrists in Japan., (© 2024 The Author(s). Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.)
- Published
- 2024
- Full Text
- View/download PDF
42. A photoswitchable CENP-E inhibitor with single blue-green light to control chromosome positioning in mitotic cells.
- Author
-
Matsuo K, Kikukawa T, Waku T, Kobori A, and Tamaoki N
- Abstract
Reversibly photoswitchable chemical tools have aided in the development of novel approaches in the biomedical field. The visible region of light should be ideal for the biological application of this approach because of its low phototoxicity and deep penetration depth compared to ultraviolet light. Herein, we report a photoswitchable centromere-associated protein E (CENP-E) inhibitor, which is controllable with low-energy blue-green light (around 500 nm) illumination. This photoswitchable tool enabled us to control CENP-E-driven chromosome movements and positioning at subcellular resolutions with low phototoxic effects. This study can contribute to the development of a unique technique for chromosome engineering., Competing Interests: There are no conflicts to declare., (This journal is © The Royal Society of Chemistry.)
- Published
- 2024
- Full Text
- View/download PDF
43. A new era in surgical oncology: preliminary insights into the hinotori™ surgical robot system's role in rectal surgery using the double bipolar method.
- Author
-
Katsuno H, Morohara K, Endo T, Chikaishi Y, Kikuchi K, Nakamura K, Matsuo K, Higashiguchi T, Koide T, Hanai T, and Morise Z
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Follow-Up Studies, Adult, Prognosis, Surgical Oncology methods, Operative Time, Lymph Node Excision methods, Lymph Node Excision instrumentation, Aged, 80 and over, Laparoscopy methods, Robotic Surgical Procedures methods, Robotic Surgical Procedures instrumentation, Rectal Neoplasms surgery, Rectal Neoplasms pathology
- Abstract
Background: The da Vinci™ Surgical System, recognized as the leading surgical robotic platform globally, now faces competition from a growing number of new robotic surgical systems. With the expiration of key patents, innovative entrants have emerged, each offering unique features to address limitations and challenges in minimally invasive surgery. The hinotori™ Surgical Robot System (hinotori), developed in Japan and approved for clinical use in November 2022, represents one such entrant. This study demonstrates initial insights into the application of the hinotori in robot-assisted surgeries for patients with rectal neoplasms., Methods: The present study, conducted at a single institution, retrospectively reviewed 28 patients with rectal neoplasms treated with the hinotori from November 2022 to March 2024. The surgical technique involved placing five ports, including one for an assistant, and performing either total or tumor-specific mesorectal excision using the double bipolar method (DBM). The DBM uses two bipolar instruments depending on the situation, typically Maryland bipolar forceps on the right and Fenestrated bipolar forceps on the left, to allow precise dissection, hemostasis, and lymph node dissection., Results: The study group comprised 28 patients, half of whom were male. The median age was 62 years and the body mass index stood at 22.1 kg/m
2 . Distribution of clinical stages included eight at stage I, five at stage II, twelve at stage III, and three at stage IV. The majority, 26 patients (92.9%), underwent anterior resection using a double stapling technique. There were no intraoperative complications or conversions to other surgical approaches. The median operative time and cockpit time were 257 and 148 min, respectively. Blood loss was 15 mL. Postoperative complications were infrequent, with only one patient experiencing transient ileus. A median of 18 lymph nodes was retrieved, and no positive surgical margins were identified., Conclusions: The introduction of the hinotori for rectal neoplasms appears to be safe and feasible, particularly when performed by experienced robotic surgeons. The double bipolar method enabled precise dissection and hemostasis, contributing to minimal blood loss and effective lymph node dissection., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
44. Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer.
- Author
-
Suzuki Y, Chen L, Matsuo K, Ferris JS, Elkin EB, Melamed A, Kong CY, Bickell N, Myers ER, Havrilesky LJ, Xu X, Blank SV, Hazelton WD, Hershman DL, and Wright JD
- Abstract
Objective: Although obesity is an important risk factor for endometrial intraepithelial neoplasia (EIN) and uterine cancer, little is known about the trends in use of weight-loss therapy for patients with obesity with EIN and uterine cancer. We examined the use of weight-loss therapy among patients with obesity with EIN and uterine cancer., Methods: The Merative MarketScan Database was used to identify patients aged 18-70 years who were obese and diagnosed with EIN or uterine cancer. The primary treatment for EIN or uterine cancer was categorized as either primary hysterectomy or hormonal therapy. Nutrition counseling, bariatric surgeries, and weight-management medications were identified as weight-loss therapy. We analyzed trends in the use of any weight-loss therapies with Cochran-Armitage tests. A multivariable logistic regression model was developed to examine factors associated with weight-loss therapy use., Results: Overall, 15,374 patients were identified, including 5561 (36.2%) patients with EIN and obesity, and 9813 (63.8%) patients with uterine cancer and obesity. Weight-loss therapy was utilized within 1 year after diagnosis in 480 (8.6%) patients with EIN and in 802 (8.2%) patients with uterine cancer. Use of any weight-loss therapy after diagnosis of EIN increased from 4.1% in 2009 to 12.6% in 2020 (P < .001), and the use of any weight-loss therapy after diagnosis of uterine cancer increased from 4.9% in 2009 to 11.4% in 2020 (P < .001). In a multivariable regression model, younger age and patients with high comorbidity score were associated with a higher likelihood of using any weight-loss therapy., Conclusions: Use of weight-loss therapy has increased, however there is still a significant underuse of this adjunctive therapy in patients with obesity with EIN or uterine cancer., Competing Interests: Declaration of competing interest Dr. Wright has received royalties from UpToDate and the American College of Obstetricians and Gynecologistsand received research funding from Merck. All other authors declare no conflicts of interest. Dr. Suzuki reports receiving payment from The Japan Society for Menopause and Women's Health (JMWH Bayer Grant 2021), from Kanzawa Medical Research Foundation (Oversea Research Grant 2022), and from Mitsui & CO. (U.S.A), INC (Mitsui USA-JMSA Scholarship 2023). Dr. Elkin has received research support from Pfizer., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. "Wire kissing technique" and "externalization and pull-through technique" for treating chronic total occlusion in hemodialysis vascular access: A case report.
- Author
-
Inoue M, Matsuo K, Tamaki T, and Hattori K
- Abstract
The construction and utilization of dependable vascular access are essential for hemodialysis. Despite its importance, complications with vascular access are common, significantly impacting patient morbidity and mortality. This report presents a novel approach to treating chronic total occlusion (CTO) in hemodialysis vascular access using the "wire kissing technique" an "externalization and pull-through technique." An 82-year-old woman on hemodialysis had a thrombotic obstruction in her cephalic vein, which conventional methods failed to address. The wire kissing technique allowed the meeting of antegrade and retrograde wires within the CTO lesion, stabilizing the wire and facilitating balloon passage. The externalization and pull-through technique further enabled the balloon to cross the rigid CTO lesion, successfully completing percutaneous transluminal angioplasty (PTA). Post-procedure ultrasonography showed significant improvements in flow volume and resistance index. These techniques, commonly used in coronary and femoral arteries, have not been previously reported for dialysis vascular access. This case highlights a novel and effective solution for overcoming technical difficulties in crossing CTO lesions, potentially improving outcomes in vascular access for hemodialysis patients., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
46. Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report.
- Author
-
Nakamura K, Nakagawa M, Ariga M, Higashiguchi T, Chikaishi Y, Matsuo K, Nishijima A, Endo T, Kikuchi K, Morohara K, Katsuno H, Tachi Y, Uyama I, Suda K, and Morise Z
- Abstract
Background: Adenosquamous carcinoma of the pancreas (ASCP) accounts for only 1-4% of all pancreatic exocrine cancers and has a particularly poor prognosis. The efficacy of chemotherapy for ASCP remains unknown because of the small number of cases, and few studies have evaluated conversion-intended chemotherapy., Case Presentation: A 76-year-old woman was referred to our hospital because of epigastric pain and nausea. A preoperative contrast-enhanced multidetector row computed tomography (MDCT) scan revealed a 17 × 17 mm low-density tumor with an ill-defined margin at the arterial phase in the pancreatic head. The tumor involved the common hepatic artery, left hepatic artery bifurcated from the common hepatic artery, and gastroduodenal artery, and was in contact with the portal vein. Fluorodeoxyglucose-positron emission tomography (FDG-PET) showed an uptake in the pancreatic head but no evidence of distant metastasis. The tumor was diagnosed as an adenocarcinoma of the pancreatic head and staged unresectable because the common and left hepatic arteries were involved. Hence, the patient underwent seven courses of conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for pancreatic ductal adenocarcinoma over 7 months. After chemotherapy, the tumor shrank to 10 × 10 mm on contrast-enhanced MDCT. Consequently, the boundary between the tumor and major vessels of the common and left hepatic arteries and the portal vein became clear, and the involvement of the arteries with the tumor was evaluated to be released. The contact of the tumor to the portal vein also reduced to less than half the circumference of the portal vein. FDG-PET showed decreased accumulation in the tumor. Hence, the tumor was judged resectable, and pancreaticoduodenectomy was performed. The tumor and major blood vessels were easily dissected and R0 resection was achieved. The patient experienced no major complications and was discharged on postoperative day 28. The tumor was revealed as ASCP via pathological examination. The patient is alive and recurrence-free seven months after surgery. This is the first report of successful R0 resection for an initially unresectable ASCP following conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen., Conclusions: Conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen may be effective for ASCP., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
47. Establishment of a novel amyotrophic lateral sclerosis patient ( TARDBP N345K/+ )-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.
- Author
-
Matsuo K, Nagamatsu J, Nagata K, Umeda R, Shiota T, Morimoto S, Suzuki N, Aoki M, Okano H, Nakamori M, and Nishihara H
- Abstract
Amyotrophic lateral sclerosis (ALS) is a major neurodegenerative disease for which there is currently no curative treatment. The blood-brain barrier (BBB), multiple physiological functions formed by mainly specialized brain microvascular endothelial cells (BMECs), serves as a gatekeeper to protect the central nervous system (CNS) from harmful molecules in the blood and aberrant immune cell infiltration. The accumulation of evidence indicating that alterations in the peripheral milieu can contribute to neurodegeneration within the CNS suggests that the BBB may be a previously overlooked factor in the pathogenesis of ALS. Animal models suggest BBB breakdown may precede neurodegeneration and link BBB alteration to the disease progression or even onset. However, the lack of a useful patient-derived model hampers understanding the pathomechanisms of BBB dysfunction and the development of BBB-targeted therapies. In this study, we differentiated BMEC-like cells from human induced pluripotent stem cells (hiPSCs) derived from ALS patients to investigate BMEC functions in ALS patients. TARDBP
N345K/+ carrying patient-derived BMEC-like cells exhibited increased permeability to small molecules due to loss of tight junction in the absence of neurodegeneration or neuroinflammation, highlighting that BMEC abnormalities in ALS are not merely secondary consequences of disease progression. Furthermore, they exhibited increased expression of cell surface adhesion molecules like ICAM-1 and VCAM-1, leading to enhanced immune cell adhesion. BMEC-like cells derived from hiPSCs with other types of TARDBP gene mutations ( TARDBPK263E/K263E and TARDBPG295S/G295S ) introduced by genome editing technology did not show such BMEC dysfunction compared to the isogenic control. Interestingly, transactive response DNA-binding protein 43 (TDP-43) was mislocalized to cytoplasm in TARDBPN345K/+ carrying model. Wnt/β-catenin signaling was downregulated in the ALS patient ( TARDBPN345K/+ )-derived BMEC-like cells and its activation rescued the leaky barrier phenotype and settled down VCAM-1 expressions. These results indicate that TARDBPN345K/+ carrying model recapitulated BMEC abnormalities reported in brain samples of ALS patients. This novel patient-derived BMEC-like cell is useful for the further analysis of the involvement of vascular barrier dysfunctions in the pathogenesis of ALS and for promoting therapeutic drug discovery targeting BMEC., Competing Interests: HO reports grants and personal fees from K Pharma, Inc. during the conduct of the study; and personal fees from Sanbio Co. Ltd., outside the submitted work; In addition, HO has a patent on a therapeutic agent for amyotrophic lateral sclerosis and composition for treatment licensed to K Pharma, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Matsuo, Nagamatsu, Nagata, Umeda, Shiota, Morimoto, Suzuki, Aoki, Okano, Nakamori and Nishihara.)- Published
- 2024
- Full Text
- View/download PDF
48. Distinct obstetric characteristics and maternal mortality in patients with HELLP syndrome versus severe pre-eclampsia.
- Author
-
Kuhn JN, Mazza GR, Matsuzaki S, Pon FF, Yao JA, Yu E, Mandelbaum RS, Ouzounian JG, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
49. Variable clinical and gynecologic characteristics associated with anatomical site of ectopic pregnancy.
- Author
-
Girma AM, Anderson ZS, Masjedi AD, Mandelbaum RS, Ouzounian JG, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
50. Management challenges and the role of adjuvant chemotherapy in remnant gastric cancer: an analysis of 313 patients from the KEGG multicenter observational study.
- Author
-
Okamura R, Aoyama R, Tsunoda S, Yamashita Y, Hata H, Kinjo Y, Miki A, Kanaya S, Yamamoto M, Matsuo K, Manaka D, Tanaka E, Kawada H, Kondo M, Itami A, Kan T, Kadokawa Y, Ito T, Jikihara S, Kasahara K, Sakamoto T, Okumura S, Maekawa H, Nishigori T, Hisamori S, and Obama K
- Abstract
Background: Clinical findings and postoperative follow-up data on remnant gastric cancer (RGC) are limited due to its rarity. Additionally, the preoperative staging, radical surgery, and managing recurrence in RGC present significant clinical challenges., Methods: We analyzed the clinicopathological findings, adjuvant chemotherapy, and patterns of postoperative recurrence of 313 consecutive patients who underwent curative surgery for RGC at 17 Japanese institutions. This study investigated the optimal management of RGC and the impact of adjuvant chemotherapy (AC) on recurrence-free survival (RFS)., Results: Pathological stages I, II, and III were observed in 55.9% (N = 175), 24.9% (N = 78), and 19.2% (N = 60) of the patients, respectively. The overall concordance rate between clinical and pathological T staging was 58.3%, with a clinical T4 sensitivity of 41.4% for diagnosing pathological T4. During the median follow-up period of 4.6 years, disease recurrence occurred in 24.3% of patients. Most recurrences (over 80%) occurred within 2.5 years, and 96.1% within 5 years after RGC surgery. Peritoneal recurrence was the most common in patients with advanced RGC, accounting for 14.1% in stage II and 28.3% in stage III. Multivariable regression analysis showed that AC was significantly associated with a longer RFS, with a hazard ratio of 0.45 (95% confidence interval: 0.26-0.76)., Conclusions: Our study underscores the importance of early detection, accurate preoperative staging, and postoperative surveillance in managing advanced RGC cases. Despite some limitations, our findings indicate that AC may provide survival benefits comparable to those seen in primary gastric cancer., (© 2024. The Author(s) under exclusive licence to The International Gastric Cancer Association and The Japanese Gastric Cancer Association.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.